HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
AMRX
Amneal Pharmaceuticals Inc - Class A
Healthcare Drug Manufacturers - Specialty & Generic · Reports in usd
Market Cap: $4.00B
Market Cap
$4.00B
Enterprise Val
$6.38B
P/E Ratio
55.56
P/B Ratio
-56.55
Trailing PEG (1Y)
-0.26
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$71.3M
Gross Margin36.50%
Profit Margin36.50%
Return on Equity-67.97%
Return on Assets2.05%
Current Ratio2.17
Debt/Equity-37.98
LT Debt/Equity-37.68
Revenue Per Share2.59

Income Statement

Dec 31, 2025
Revenue$814.3M
Cost of Revenue$517.1M
Gross Profit$297.2M
R&D$34.8M
SG&A$146.5M
Operating Expenses$185.2M
Operating Income$112.0M
Interest Expense$56.2M
Tax Expense$5.7M
Net Income$35.1M
EPS (Basic)$0.11
EPS (Diluted)$0.11
EBIT$97.0M
EBITDA$146.2M
Consolidated Income$49.6M
Non-Controlling Interests$14.5M

Balance Sheet

Dec 31, 2025
Cash & Equivalents$310.9M
Accounts Receivable$895.6M
Inventory$606.3M
Current Assets$1.91B
LT Investments$0.00
Property, Plant & Equipment$550.3M
Intangibles$1.16B
Non-Current Assets$1.77B
Total Assets$3.68B
Accounts Payable$780.4M
Current Debt$21.6M
Current Liabilities$881.6M
LT Debt$2.67B
Non-Current Liabilities$2.87B
Total Liabilities$3.75B
Total Debt$2.69B
Retained Earnings-$535.0M
Shareholder Equity-$70.8M
Shares Outstanding314,362,920

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$130.3M
Investing Cash Flow-$45.5M
Financing Cash Flow-$10.1M
CapEx-$42.5M
Free Cash Flow$87.9M
Depreciation & Amort.$49.2M
Stock-Based Comp$8.2M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$81.1M
Equity Issued/Repaid$553.0K
Dividends Paid$0.00
Net Change in Cash$74.5M
Data cached · Meta live · Daily live · Statements live · TTL 24h